or Try an Advanced Search...

    Technical Analysis for OPTN - OptiNose, Inc.

    Grade Last Price % Change Price Change
    F 0.46 -10.29% -0.05
    OPTN closed down 10.29 percent on Thursday, November 14, 2024, on 2.54 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical OPTN trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    New 52 Week Low Weakness 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Older End-of-Day Signals for OPTN ...

       Recent Intraday Alerts

    Alert Time
    Down 1 ATR about 19 hours ago
    2x Volume Pace about 19 hours ago
    1.5x Volume Pace about 19 hours ago
    Down 10% about 19 hours ago
    60 Minute Opening Range Breakdown about 19 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    OPTN Chart by TradingView
    Basic chart:

    Profile

    OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The Company’s lead product, XHANCE (fluticasone propionate) nasal spray, utilizes breath powered exhalation delivery system (EDS), to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. XHANCE has a differentiated clinical profile with the potential to become part of the standard of care for this disease because it is able to deliver medication to the primary site of inflammation
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Clinical Medicine Pharmaceutical Disease Organ Systems Inflammation Allergy Respiratory Therapy Polyp Sinus Glucocorticoids Chronic Rhinosinusitis Corticosteroid Sinusitis Fluticasone Nasal Polyps Nasal Spray

    Is OPTN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 OptiNose Third Quarter 2024 Earnings: EPS: US$0.002 (vs US$0.083 loss in 3Q 2023)
    Nov 13 OptiNose Inc (OPTN) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Revised Guidance
    Nov 13 Q3 2024 OptiNose Inc Earnings Call
    Nov 12 OptiNose, Inc. (OPTN) Q3 2024 Earnings Call Transcript
    Nov 12 OptiNose, Inc. 2024 Q3 - Results - Earnings Call Presentation
    Nov 12 OptiNose (OPTN) Reports Break-Even Earnings for Q3
    Nov 12 OptiNose gives mixed
    Nov 12 Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights
    Nov 12 Earnings Scheduled For November 12, 2024
    Nov 11 Strength Seen in electroCore (ECOR): Can Its 6.0% Jump Turn into More Strength?
    See more OPTN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.1
    52 Week Low 0.4412
    Average Volume 496,432
    200-Day Moving Average 1.09
    50-Day Moving Average 0.74
    20-Day Moving Average 0.71
    10-Day Moving Average 0.66
    Average True Range 0.07
    RSI (14) 25.37
    ADX 24.8
    +DI 12.90
    -DI 40.32
    Chandelier Exit (Long, 3 ATRs) 0.61
    Chandelier Exit (Short, 3 ATRs) 0.64
    Upper Bollinger Bands 0.90
    Lower Bollinger Band 0.52
    Percent B (%b) -0.19
    BandWidth 52.62
    MACD Line -0.05
    MACD Signal Line -0.02
    MACD Histogram -0.0237
    Fundamentals Value
    Market Cap 51.1 Million
    Num Shares 112 Million
    EPS -0.38
    Price-to-Earnings (P/E) Ratio -1.20
    Price-to-Sales 2.09
    Price-to-Book 24.26
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.59
    Resistance 3 (R3) 0.60 0.56 0.57
    Resistance 2 (R2) 0.56 0.53 0.56 0.56
    Resistance 1 (R1) 0.51 0.51 0.49 0.50 0.55
    Pivot Point 0.48 0.48 0.47 0.47 0.48
    Support 1 (S1) 0.42 0.44 0.40 0.41 0.36
    Support 2 (S2) 0.39 0.42 0.38 0.35
    Support 3 (S3) 0.33 0.39 0.34
    Support 4 (S4) 0.32